Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics.

Saved in:
Bibliographic Details
Title: Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics.
Authors: Garcia-Pavia P; Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain. Electronic address: pablogpavia@yahoo.es., Bilen O; Emory University Medical Center, Atlanta, Georgia, USA., Burroughs M; Wellstar Health System, Atlanta, Georgia, USA., Costabel JP; Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina., de Barros Correia E; Dante Pazzanese Institute of Cardiology, São Paulo, Brazil., Dybro AM; Aarhus Hospital University, Aarhus, Denmark., Elliott P; Barts Heart Centre and University College London, London, United Kingdom., Lakdawala NK; Brigham and Women's Hospital, Boston, Massachusetts, USA., Mann A; Colorado Springs, Colorado, USA., Nair A; Baylor College of Medicine, Houston, Texas, USA., Nassif ME; University of Missouri Kansas City Healthcare Institute of Innovations in Quality and Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA., Poulsen SH; Aarhus Hospital University, Aarhus, Denmark., Reant P; University Hospital Center of Bordeaux, CIC-P 1401, University of Bordeaux, Bordeaux, France., Schulze PC; University Hospital Jena, Friedrich-Schiller-University, Jena, Germany., Wang A; Duke University Medical Center, Durham, North Carolina, USA., Berhane I; Cytokinetics, South San Francisco, California, USA., Heitner SB; Cytokinetics, South San Francisco, California, USA., Jacoby DL; Cytokinetics, South San Francisco, California, USA., Kupfer S; Cytokinetics, South San Francisco, California, USA., Malik FI; Cytokinetics, South San Francisco, California, USA., Meng L; Cytokinetics, South San Francisco, California, USA., Sohn R; Cytokinetics, South San Francisco, California, USA., Wohltman A; Cytokinetics, South San Francisco, California, USA., Fifer MA; Massachusetts General Hospital, Boston, Massachusetts, USA.
Corporate Authors: MAPLE-HCM Study Investigators
Source: JACC. Heart failure [JACC Heart Fail] 2025 Feb; Vol. 13 (2), pp. 346-357.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-1787
DOI:10.1016/j.jchf.2024.11.011